Startups

Director, GxP Quality Governance and Partnerships

Revolution Medicines · Remote (United States) · Remote

← All jobs
About Revolution Medicines

Backed by GV.

About the role

The Director, GxP Quality Governance & Partnerships will provide Quality leadership in establishing and managing Quality Agreements and related arrangements supporting Revolution Medicines’ expanding global development, manufacturing, and commercial operations. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s degree in life sciences, technical, or related field with 12+ years of experience in the biotechnology, pharmaceutical, or medical device industry
  • Lead the development, review, negotiation, and execution of Quality Agreements and related Quality arrangements supporting clinical development and global commercial operations
  • Manage agreements involving CMOs, CDMOs, contract laboratories, packaging and distribution partners, clinical collaborations, other GxP service providers, and intra-company arrangements
  • Establish clear Quality responsibilities, decision-making authority, oversight expectations, and communication requirements across internal and external partnerships
  • Collaborate with Quality, Legal, Development, Manufacturing, Supply Chain, Strategic Sourcing, CMC Regulatory, and other stakeholders to align Quality Agreements with business contracts, operational needs, and applicable regulatory requirements
  • Lead the resolution of complex agreement-related issues and negotiations, making timely, risk-based decisions and escalating significant risks or unresolved matters to the appropriate leadership or cross-functional teams
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Director, GxP Quality Governance & Partnerships will provide Quality leadership in establishing and managing Quality Agreements and related arrangements supporting Revolution Medicines’ expanding global development, manufacturing, and commercial operations.

The Director will lead the development, negotiation, implementation, and lifecycle management of Quality Agreements across a diverse...

Read the full posting on Revolution Medicines's site ↗

Quality Assurance

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.